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Abstract
Introduction: Cardiac surgery is frequently needed in patients with infective endocarditis (IE). Acute kidney injury
(AKI) often complicates IE and is associated with poor outcomes. The purpose of the study was to determine the
risk factors for post-operative AKI in patients operated on for IE.
Methods: A retrospective, non-interventional study of prospectively collected data (2000–2010) included patients
with IE and cardiac surgery with cardio-pulmonary bypass. The primary outcome was post-operative AKI, defined as
the development of AKI or progression of AKI based on the acute kidney injury network (AKIN) definition. We used
ensemble machine learning (“Super Learning”) to develop a predictor of AKI based on potential risk factors, and
evaluated its performance using V-fold cross validation. We identified clinically important predictors among a set of
risk factors using Targeted Maximum Likelihood Estimation.
Results: 202 patients were included, of which 120 (59%) experienced a post-operative AKI. 65 (32.2%) patients
presented an AKI before surgery while 91 (45%) presented a progression of AKI in the post-operative period. 20
patients (9.9%) required a renal replacement therapy during the post-operative ICU stay and 30 (14.8%) died during
their hospital stay. The following variables were found to be significantly associated with renal function impairment,
after adjustment for other risk factors: multiple surgery (OR: 4.16, 95% CI: 2.98-5.80, p<0.001), pre-operative anemia
(OR: 1.89, 95% CI: 1.34-2.66, p<0.001), transfusion requirement during surgery (OR: 2.38, 95% CI: 1.55-3.63, p<0.001),
and the use of vancomycin (OR: 2.63, 95% CI: 2.07-3.34, p<0.001), aminoglycosides (OR: 1.44, 95% CI: 1.13-1.83,
p=0.004) or contrast iodine (OR: 1.70, 95% CI: 1.37-2.12, p<0.001). Post-operative but not pre-operative AKI was
associated with hospital mortality.
Conclusions: Post-operative AKI following cardiopulmonary bypass for IE results from additive hits to the kidney.
We identified several potentially modifiable risk factors such as treatment with vancomycin or aminoglycosides or
pre-operative anemia.
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Introduction
Early surgical treatment has been suggested to improve
the outcome of patients with infective endocarditis (IE)
[1]. Acute kidney injury (AKI) is a common complication
following cardiac surgery, occurring in 5 to 20% of the
patients [2-5]. It has been associated with increased
mortality [3,6,7]. Furthermore, AKI has been reported
to be associated with poor prognosis in patients with acute
IE [8-10]. There is therefore a need to prevent episodes of
post-operative AKI, which may improve the outcome.
Patients with IE are typically at risk of kidney injury
and their renal function might further be compromised
because of cumulative injuries occurring before, during
and after surgery. However, there are limited data on the
prognosis of AKI in patients with IE undergoing cardiac
surgery, and particularly, the risk factors favoring post-
operative worsening of renal function in this context are
not well-described. The aim of the present study was
to describe the incidence of AKI patients undergoing
operation for an acute episode of endocarditis, and to
identify the risk factors for post-operative AKI or worsening
of renal function in these patients.
Materials and methods
Patients
Between January 2000 and December 2010, all consecu-
tive patients admitted to the Hôpital Européen Georges
Pompidou (Paris, France), an 800-bed university hospital
with a dedicated infectious unit specializing in treatment
of patients with IE, with the diagnosis of IE according to
the modified Duke criteria [11] and who underwent cardiac
surgery with cardiopulmonary bypass were included.
The study was approved by our local ethical committee
(CEERB Paris Nord) and no consent was needed. The
indications for surgery were refractory congestive heart
failure, endocarditis-related dysfunction of native or pros-
thetic valve, uncontrolled infection, perivalvular extension
of infection, systemic embolic episode or large vegetation.
The patients who died within the first 24 hours following
surgery and those who needed pre-operative renal replace-
ment therapy (RRT) for any reason were excluded from
the analysis.
Data collection
Epidemiological, clinical and biological data were pro-
spectively collected using a standardized case report form.
Clinical and epidemiological data collected are presented
in Table 1.
Outcome measure
The main goal of the present study was to identify the
risk factors for worsening of renal function during the
peri-operative period in patients operated on for an acute
episode of IE. Therefore, the primary outcome measure
was post-operative AKI, defined as the development or
the progression of AKI during the seven days following
cardiac surgery with cardiopulmonary bypass. Explicitly,
post-operative AKI was defined as (1) the development of
AKI in patients with normal renal function before surgery,
or (2) the progression of AKI when AKI was already
present before surgery.
We used the acute kidney injury network (AKIN) classi-
fication [12] to define and stage AKI. AKI was defined as
an increase of serum creatinine >50% or >26 μmol/l from
baseline (stage 1 of the AKIN definition). In patients with
pre-operative AKI, progression of AKI was defined as a
post-operative increase in the stage of AKI or a need for
RRT during the 7 days following surgery. Baseline serum
creatinine was retrieved from the blood sample obtained
before hospital admission, when available. When the base-
line creatinine level was not available, the lowest serum
creatinine level measured during the hospital stay was
used if the glomerular filtration rate (GFR) was ≥75 mL/
minute/1.73 m2. In the remaining cases, serum creatinine
was estimated by the modification of diet in renal disease
(MDRD) equation using a GFR of 75 mL/minute/1.73 m2.
Statistical analysis
We first developed a prediction model for post-operative
AKI based on the approach known as super learning,
and then identified the most important risk factors using
targeted maximum likelihood estimation (TMLE).
Super learner
The discrete super learner has been proposed by Dudoit
and Van der Laan et al. [13] as a generalization of the
stacking algorithms [14], to choose the optimal regression
algorithm among a set of candidates. The underlying selec-
tion strategy relies on the choice of a loss function, which
aims at evaluating the gap between the actual and the
predicted outcomes for each candidate. The comparison
between candidates relies on V-fold cross-validation: the
dataset is divided into V mutually exclusive and exhaustive
subsets of nearly equal size. At each V step of the proced-
ure, one of the V sets serves as a validation set, while the
others play the role of training sets for each candidate
algorithm. Observations in the training set are used to con-
struct the estimators, and observations in the validation set
are used to assess the performance of the estimators, the
so-called risk, on the basis of the chosen loss function (L2
or squared error in the present study). At the end of the
procedure, each set has served both as the training and
validation sample. For each candidate algorithm, the super
learner then averages the V estimated risks over the V
validation sets, resulting in the so-called cross-validated
risk, for each candidate algorithm. Based on their cross-
validated risks, the candidate estimators can be ranked
and the optimal learner is finally applied to the entire
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dataset. Finally, a weighted linear combination of the
candidate learners is used to build a new estimator, the
so-called super learner estimator [15].
We investigated the following algorithms: generalized
additive model, generalized linear model, stepwise re-
gression (forward and based on the Akaike information
criterion (AIC)), polynomial linear model, random forest,
neural network, Bayesian generalized linear model, elastic-
net regularized generalized linear model, polynomial spline
regression and gradient boosting. The set of explanatory
variables encompassed age, gender, pre-existing comor-
bidities (history of heart failure, chronic respiratory failure,
hypertension, diabetes, coronary artery disease, autoimmune
disease, cancer, liver disease or previous endocarditis),
health status before surgery (presence of shock, systemic
emboli, New York Heart Association (NYHA) classifica-
tion, hemoglobin levels, baseline creatinine levels, or need
for mechanical ventilation), characteristics of the infection
Table 1 Patients’ characteristics
All patients
(n = 202)
No post-operative
AKI (n = 82)
Post-operative
AKI (n = 120)
P-value
Age, years, median (IQR) 42 (28 to 59) 50 (37 to 66) 36 (27 to 51) <0.001
Gender, male, n (%) 134 (66.3) 49 (59.8) 85 (70.8) 0.14
Comorbidities, n (%)
COPD 9 (4.4) 2 (2.4) 7 (5.8) 0.42
Diabetes mellitus 22 (10.9) 7 (8.5) 15 (12.5) 0.63
Hypertension 60 (29.7) 22 (26.8) 38 (31.7) 0.56
Heart failure 13 (6.4) 3 (3.7) 10 (8.3) 0.30
CAD 11 (5.4) 3 (3.7) 8 (6.7) 0.54
Autoimmune disease 8 (4.0) 4 (4.9) 4 (3.3) 0.85
Liver disease 17 (8.4) 5 (6.1) 12 (10.0) 0.47
Cancer 17 (8.4) 6 (7.3) 11 (9.2) 0.84
Pre-operative condition
Mechanical ventilation, n (%) 16 (7.9) 2 (2.4) 14 (11.7) 0.03
Cathecolamine use, n (%) 18 (8.9) 4 (4.9) 14 (11.7) 0.16
Norepinephrine, (%) 9 (4.4) 1 (1.2) 8 (6.7) 0.13
Epinephrine, n (%) 3 (1.5) 0 (0) 3 (2.5) 0.39
Dobutamine, n (%) 9 (4.4) 4 (4.9) 5 (4.2) 1
% LVEF, median (IQR) 65 (60 to 70) 65 (60 to 70) 65 (58 to 70) 0.10
Baseline serum creatinine, μmol/l, median (IQR) 83 (75 to 100) 78 (62 to 86) 90 (80 to 100) <0.001
Pre-operative serum creatinine, μmol/l, median (IQR) 100 (76 to 132) 77 (62 to 100) 116 (91 to 157) <0.001
Bilirubin, mg/ml, median (IQR) 13 (10 to 20) 12 (9 to 15) 14 (11 to 22) 0.02
Platelet count, G/l, median (IQR) 249 (187 to 319) 261 (205 to 324) 244 (173 to 307) 0.06
CRP, median (IQR) 51 (11 to 87) 46 (17 to 106) 67 (30 to 159) 0.10
Hemoglobin, g/dl, median (IQR) 10.8 (9.5 to 11.9) 11 .3 (10.3 to 12.3) 10.3 (9.1 to 11.4) <0.001
Pre-operative nephrotoxic agents, n (%)
Contrast agent 94 (46.5) 36 (43.9) 58 (48.3) 0.63
Vancomycin 36 (17.8) 6 (7.3) 30 (25.0) 0.002
Aminoglycoside 119 (58.9) 45 (54.9) 74 (61.7) 0.41
Surgery
Emergency surgery, n (%) 27 (13.4) 9 (11.0) 18 (15.0) 0.54
CPB duration, minutes, median (IQR) 118 (85 to 163) 100 (76 to 142) 118 (95 to 1800 0.004
Aortic clamping duration, minutes, median (IQR) 89 (65 to 121) 76 (59 to 100) 90 (74 to 132) 0.002
Circulatory arrest, n (%) 5 (2.5) 2 (2.4) 3 (2.5) 1
AKI, acute kidney injury; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; LVEF, left ventricular ejection fraction; CPB, cardiopulmonary
bypass; CRP, C reactive protein.
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(cardiac valve involvement, multiple valve infection,
infection of native versus prosthetic valve, presence of
pacemaker infection, or presence of positive blood cul-
tures), characteristics of the surgery (emergency surgery
within 24 h of admission, cardiopulmonary bypass duration,
aortic clamping duration, circulatory arrest, implantation
of a bioprothesis versus mechanical valve, valvular
plasty, aortic tube, multiple surgery), use of nephrotoxic
agents (contrast agents, aminoglycoside, or vancomycin)
within 48 h prior to surgery and the following interactions
terms: vancomycin-aminoglycoside, vancomycin-contrast,
aminoglycoside-contrast. Pre-operative hemoglobin level
before surgery was assessed on the day of surgery, multiple
surgery was defined as a least one revision surgery. The
risks associated with the different estimators were evalu-
ated using the area under the receiver operating curve
(AUROC), based on cross-validation.
Targeted maximum likelihood estimation for variable
importance measure
In order to identify the most important risk factors for
post-operative AKI, we used the TMLE approach. The
variables considered as potential risk factors were: age;
gender; pre-existing comorbidities (history of heart failure,
chronic respiratory failure, hypertension, diabetes, coronary
artery disease, autoimmune disease, cancer, liver disease
or previous endocarditis); health status before surgery
(presence of shock, systemic emboli, NYHA classification,
hemoglobin levels, baseline creatinine levels, or need for
mechanical ventilation); characteristics of the infection
(cardiac valve involvement, multiple valve infection, infec-
tion of native versus prosthetic valve, presence of pace
maker infection, or presence of positive blood cultures);
characteristics of the surgery (emergency surgery within
24 h of admission, cardiopulmonary bypass duration,
aortic clamping duration, circulatory arrest, implantation
of a bioprothesis versus mechanical valve, valvular
plasty, aortic tube, or multiple surgery); transfusion re-
quirement during surgery; the use of nephrotoxic agents
(contrast agents, aminoglycoside, or vancomycin) within
48 hours prior to surgery; and the following interactions
terms: vancomycin-aminoglycoside, vancomycin-contrast,
aminoglycoside-contrast.
Continuous variables that were considered as target
parameters were dichotomized as follows: age < or ≥65 y,
NYHA classification < or ≥III, baseline creatinine ≤ or >106
μmol/l, baseline hemoglobin < or ≥10 g/dl, extracorporeal
circulation duration ≤ or >120 minutes, aortic clamping
duration ≤ or >90 minutes. These thresholds were chosen
according to the risk factors for AKI post-cardiac surgery,
as identified by Palomba et al. [2]. For each potential risk
factor, a variable importance measure was obtained adjusted
after for all other risk factors [16-18]. The parameter
targeted for measuring the importance of each covariate
was the average difference in the outcome given the level
of the candidate risk factor, after adjusting for all other
covariates.
TMLE is a two-step procedure: first, running an initial re-
gression to fit the expected value of the outcome given the
covariate of interest (that is, the candidate risk factor in our
situation) and adjusting for all other covariates. This first
step may involve super learning; second, updating the initial
regression relying on a fit of the propensity score, in order
to obtain an optimal bias-variance trade-off for the param-
eter of interest. This procedure is repeated for each target
parameter. Standard errors for the estimators of all targeted
parameters are calculated using a stacked influence curve.
Statistical inference for the vector of target parameters is
based on this multivariate normal distribution to assess
the uncertainty of the estimator. The results are expressed
as relative risk and odds ratio (OR), together with their
95% confidence intervals, and the corresponding P-values.
Continuous variables are presented as median (IQR).
All analyses were performed using R 2.15.1 statistical
software running on a Mac OsX platform (SuperLearner
and tmle packages, The R Foundation for Statistical
Computing, Vienna, Austria).
Results
Patients’ characteristics
Characteristics of patients are presented in Table 1: 223
consecutive patients were screened. Among them, 21 were
excluded (9 because of RRT before surgery, 4 did not
undergo surgery, 5 died during surgery, 3 had incomplete
files) and 202 patients were included with a median age of
42 (28 to 59) years. Male patients numbered 134 (66.3%):
19 (9.4%) patients had a previous history of IE.
The median time between onset of symptoms and
diagnosis of IE was 15 days (2 to 44). Eighteen patients
(9.1%) were in shock prior to surgery, including three
(1.5%) who had an episode of circulatory arrest. Seventy-
nine patients (39.1%) had symptoms of decompensated
heart failure (NYHA functional class III or IV). Eighty-
three patients (41.1%) had systemic embolism prior to
surgery. The median hospital and ICU lengths of stay
were of 34 (20 to 55) days, and 4 (2 to 8) days respectively.
The total duration of mechanical ventilation ranged from
1 to 46 days, with a median of 1 (1 to 3) days.
Surgery
Emergency surgery was required in 27 (13.4%) patients.
The median time between diagnosis and surgery was 12
days (3 to 32). Surgery involved the aortic valve in 104
(51.5%) patients, mitral valve in 103 (51%), pulmonary
valve in 3 (1.5%), and tricuspid valve in 20 (9.9%) patients.
Thirty-five (17.3%) patients had prosthetic valves, and 28
(13.9%) had surgery involving multiple valvular sites. A
pacemaker infection was diagnosed in 19 (9.4%) patients.
Legrand et al. Critical Care 2013, 17:R220 Page 4 of 10
http://ccforum.com/content/17/5/R220
There were 34 (16.8%) mechanical valves and 112 (55.4%)
bioprosthetic valves implanted. Valvular plasties were
performed in 66 patients (32.7%). One patient (0.5%) had
a concomitant coronary artery bypass graft, and fourteen
(6.9%) underwent ascending aorta replacement using a
prosthetic tube. Median duration of extracorporeal
circulation was 118 (85 to 163) minutes, and median
duration of aortic cross-clamping was 89 (65 to 121)
minutes. Circulatory arrest was necessary in five (2.5%)
patients. A second operation (or more) was necessary in
29 (14.4%) patients. The main reasons were: tamponnade
(n = 12, 41.4%), valve dysfunction (n = 6, 20.7%) and
mediastinitis (n = 4, 13.8%).
Microbiology
The causative pathogens are presented in Table 2. The
three most frequently involved species were: streptococci
(n = 84, 41.6%), staphylococci (n = 56, 27.8%) and entero-
cocci (n = 18, 8.9%). Blood cultures were positive in 155
(76.7%) patients.
Renal function and prognosis
Sixty-five patients (32.2%) presented with AKI before
surgery, and 137(67.8%) had normal renal function before
surgery. Of the 65 patients with pre-operative AKI, 52
(80%) were in AKIN stage 1, 9 (13.8%) in stage 2 and 4
(6.2%) in stage 3. A flow chart depicting the evaluation of
renal function throughout the peri-operative period is
provided in Figure 1. The evolution of serum creatinine
in the peri-operative period is separately described in
Figure 2.
A total of 120 (59.4%) patients met the criteria for AKI
in the post-operative period: 64 (46.7%) of the 137 patients
without pre-operative AKI and 56 (86.1%) of the 65
patients with pre-operative AKI. Among the 65 patients
with pre-operative AKI, 9 (13.8%) recovered during the 7
days following surgery, 29 (44.6%) had no AKI progression,
and 27 (41.6%) experienced AKI progression (that is,
worsening in their AKI stage).
A total of 20 patients (9.9%) required RRT during the
post-operative ICU stay. The delay between ICU admis-
sion and the initiation of RRT was 1.5 (1 to 3) days.
Association between acute kidney injury and patients’
outcomes
Thirty patients (14.8%) died during their hospital stay.
Mortality was associated with the presence/absence of
AKI. The association was not statistically significant when
considering pre-operative AKI only: 16 (11.7%) patients
without pre-operative AKI died versus 14 (21.5%) patients
with pre-operative AKI (P = 0.09 for univariate analysis).
However, the association between post-operative AKI and
mortality was statistically significant: 2 (2.4%) patients
without post-operative AKI died, and 28 (23.3%) patients
with post-operative AKI died during their hospital stay
(P <0.001 for univariate analysis). AKI stage was also
associated with mortality: 18 (52.9%) patients who experi-
enced AKI stage 3 during the peri-operative period died,
but only 12 (7.1%) of the patients who did not reach stage
3 died during their hospital stay (P <0.001 for univariate
analysis). The course of AKI during the peri-operative
period was also strongly associated with mortality: among
Table 2 Microbiology
All patients (n = 202) No post-operative AKI (n = 82) Post-operative AKI (n = 120) P-value
Streptococci 84 (41.6) 40 (48.8) 44 (36.7) 0.40
Streptococcus bovis/gallolyticus 14 (6.9) 5 (6.1) 9 (7.5) NA
Oral streptococci 36 (17.8) 19 (23.2) 17 (14.2) NA
Pyogenic streptococcia 15 (7.4) 8 (9.8) 7 (5.8) NA
Others Streptococcaceaeb 19 (9.4) 8 (9.8) 11 (9.2) NA
Staphylococci 56 (27.8) 14 (17.1) 42 (35.0) 0.008
Staphylococcus aureus 38 (18.8) 9 (11.0) 29 (24.2) 0.03
Coagulase-negative staphylococci 18 (8.9) 5 (6.1) 13 (10.8) 0.16
Enterococcus faecalis 18 (8.9) 6 (7.3) 12 (10.0) 0.68
HACEK group 10 (4.9) 6 (7.3) 4 (3.3) 0.66
Bartonella species 10 (4.9) 6 (7.3) 4 (3.3) 0.34
Coxiella burnetii 3 (1.5) 1 (1.2) 2 (1.7) 0.99
Others microorganismsc 18 (8.9) 9 (11.0) 9 (7.5) 0.55
Negative culture bacteria d 3 (1.5) 0 (0) 3 (2.5) 0.39
aBeta-hemolytic streptococci (group A,B,C and G); bOthers streptococci: Streptococcus pneumoniae (n = 6), Peptostreptocccus (n = 2), Abiotrophia defectiva (n = 1),
Gemella species (n = 3), Streptococcus acidominimus (n = 1), Streptococcus anginosus (n = 1), Streptococcus deficiens (n = 1), Streptococcus spp (n = 4); cOthers
micororganisms: Serratia marcescens (n = 1), Klebsiella pneumoniae (n = 1), Proprionobacterium species (n = 5), Candida species (n = 1), Aspergillus species (n = 1),
Campylobacter species (n = 1); others (n = 8); dFor the three patients with negative cultures, the direct examination revealed Gram-positive Cocci; HACEK,
Haemophilus sp, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella kingae; NA, not applicable.
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the patients whose renal function improved, only one
(6.2%) died, three (3.2%) of the patients whose renal
function remained stable died, and 26 (28.6%) of those
whose renal function deteriorated died during their
hospital stay (P <0.001 for univariate analysis) (Figure 3).
The AKI stage was also significantly associated with
the duration of mechanical ventilation (P <0.001) and the
ICU length of stay (P <0.001), but not with the hospital
length of stay (P = 0.08).
Prediction of renal function worsening after surgery
The first step was to predict post-operative AKI during the
seven days following surgery. Of the candidate algorithm
considered for prediction, stepwise regression AIC had
the lowest cross-validated mean squared prediction error.
The cross-validated AUROC for this algorithm was 0.757
(95% CI 0.689, 0.826) (Additional file 1). The super learner
weighted estimator achieved an estimated AUROC of 0.760
(95% CI 0.694, 0.826).
Variable importance measure estimated using TMLE
identified the following risk factors for post-operative
AKI (Table 3): multiple surgery (OR 4.16, 95% CI 2.98,
5.80, P <0.001), pre-operative anemia as defined by a
baseline hemoglobin level <10 g/dl (OR 1.89, 95% CI 1.34,
2.66, P <0.001), transfusion requirement during surgery
(OR 2.38, 95% CI 1.55, 3.63, P <0.001), the use of a
nephrotoxic agent: vancomycin (OR 2.63, 95% CI 2.07,
3.34, P <0.001), aminoglycoside (OR 1.44, 95% CI 1.13,
1.83, P = 0.004) or contrast iodine (OR 1.70, 95% CI 1.37,
2.12, P <0.001); and the interaction between vancomycin
and aminoglycoside (OR 2.62, 95% CI 2.08, 3.31, P <0.001).
On the contrary, age over 65 y was found to protect for
experiencing the outcome (OR 0.41, 95% CI 0.30, 0.57,
P <0.001). However, when comparing middle-aged pa-
tients (40 to 75 y) to the elderly (>75 y), the effect of
age was no longer significant (OR 0.80, 95% CI 0.55,
1.18, P = 0.26).
Discussion
The present study aimed to investigate the incidence, risk
factors and prognosis associated with the post-operative
Figure 1 Flow chart of patients. AKI, acute kidney injury.
Figure 2 Evolution of serum creatinine during the peri-operative
period. AKI, acute kidney injury.
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AKI during the seven days following cardiac surgery for
IE. We identified multiple surgery, pre-operative anemia,
transfusion requirement during surgery and the use of
nephrotoxic agents within 48 hours before surgery, to be
significant risk factors.
In this study we restricted our analysis to patients with
IE requiring cardiac surgery, for several reasons. First, the
role of surgery in the treatment of IE has been emphasized
with recent studies, suggesting that early surgical manage-
ment could decrease the risk of stroke and death [1,19].
Second, most patients treated medically have contraindi-
cations to surgery, such as severe comorbid conditions or
poor performance status. In the latter patients, prior con-
ditions may per se strongly increase the risk of mortality
or morbidities [20]. Third, although risk factors for AKI
following cardiac surgery have been previously studied,
patients with IE are likely to differ because of the ongoing
inflammatory and infectious processes. Even though
surgery aims to control the infectious process, we hypoth-
esized that the accumulation of injuries, such as infection,
systemic inflammation related to the cardiopulmonary
bypass or the use of nephrotoxic agents, further increase
the risk of renal failure after surgery in such patients. We
finally confirmed that patients with IE have a high risk of
post-operative AKI following cardiac surgery [2-4].
We identified pre-operative anemia as a risk factor for
post-operative AKI. Our findings are in line with the study
from Karkouti et al. who observed a relationship between
pre-operative hemoglobin and AKI after cardiopulmonary
bypass [21,22]. The reasons for such an association are
likely multifactorial. Several experimental studies have
stressed the susceptibility of the kidney to anemia, and the
occurrence of renal hypoxia after decrease of hemoglobin
level due to maintenance of high oxygen consumption
and intrarenal oxygen shunting [23]. In a rat model where
renal oxygen tension was altered by hemodilution despite
normal arterial blood pressure [24], a specific contribution
of anemia to kidney damage through oxidative stress has
been proposed [25]. Moreover, we found that red blood
cell (RBC) transfusion per se was also a risk factor. Several
authors have previously identified the negative impact of
RBC transfusion on renal function after cardiac surgery.
One of the reasons could be the inability of RBC transfusion
to restore adequate microcirculatory oxygenation because
of the multiple morphological and functional changes
(less deformability, depletion of 2,3-diphosphoglycerate,
inflammation, decrease of bioavailability of nitric oxide
with liberation of free hemoglobin) occurring during blood
storage.
Peri-operative administration of nephrotoxic agents, such
as vancomycin, aminoglycosides or contrast iodine, was
also found to be a risk factor. Furthermore, the interaction
between vancomycin and aminoglycosides was also found
to be a significant risk factor. This would suggest that these
two drugs, when administrated together, might have
potentialized nephrotoxicity. Vancomycin-induced nephro-
toxicity has been much debated. Vancomycin has been
Figure 3 Survival according to the evolution of kidney function.
AKI, acute kidney injury.
Table 3 Factors associated with impairment in renal function after surgery
RR 95% CI P-value OR 95% CI P-value
Multiple surgery 1.83 1.54, 2.18 <0.001 4.16 2.98, 5.80 <0.001
Vancomycin administration 1.57 1.37, 1.81 <0.001 2.63 2.07, 3.34 <0.001
Aminoglycoside administration 1.23 1.07, 1.41 0.004 1.44 1.13, 1.83 0.004
Vancomycin:aminoglycoside interaction 1.54 1.34, 1.76 <0.001 2.62 2.08, 3.31 <0.001
Contrast agent 1.33 1.18, 1.51 <0.001 1.70 1.37, 2.12 <0.001
Transfusion 1.62 1.27, 2.07 <0.001 2.38 1.55, 3.63 <0.001
Pre-operative hemoglobin (<10 g/dl) 1.39 1.15, 1.67 0.001 1.89 1.34, 2.66 <0.001
Age (>65 y) 0.57 0.47, 0.70 <0.001 0.41 0.30, 0.57 <0.001
The variable importance measure for the risk factors associated with post-operative renal function impairment was performed after adjusting for all other
covariates. RR, relative risk, OR, odds ratio.
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described as nephrotoxic in patients with IE, in critically ill
patients, especially after prolonged administration. High
values for serum trough concentrations of vancomycin
have been associated with an increased risk of AKI [26,27].
However maintenance of higher trough concentration is
often required in serious methicillin-resistant Staphylo-
coccus aureus infections because of the high minimum
inhibitory concentration. Alternative strategies using less
nephrotoxic antibiotics, such as daptomycin, certainly
merits further evaluation in patients undergoing operation
for IE [28,29]. Although aminoglycosides are well-known
nephrotoxic agents, they have been scarcely studied in
patients with IE and their indication remains debated [30].
Buchholtz et al. have specifically explored the nephrotoxic
effects of aminoglycosides in patients with IE and observed
that worsening of renal function correlated with the
duration of gentamicin treatment [31]. Pooling together
the results of four randomized controlled trials that
included patients with IE, the relative risk of nephrotoxicity
was 2.22 (95% CI 1.11, 4.35) in patients treated with
aminoglycosides [32]. Consistently, in a recent randomized
controlled trial, Fowler et al. reported fewer episodes of
renal failure in patients treated with daptomycin compared
with patients receiving aminoglycosides for IE (11 versus
26% respectively) [28]. Moreover, regarding risk associa-
ted with iodine contrast in our series, the benefit of
contrast-enhanced computer tomography or angiography
pre-operatively should be balanced with the risk to renal
function. Finally, we identified multiple surgery as another
risk factor for post-operative worsening of renal function.
Multiple surgery exposes the kidney to repeated factors
of aggression, including hemodynamic instability, renal
venous congestion when tamponnade occurs, inflammatory
response to cardiopulmonary bypass, anemia and RBC
transfusions. We found that receiving several nephrotoxic
agents in the 48 hours before surgery was an important
risk factor for post-operative AKI. We realize that these
agents are sometimes needed, but we highlight that this
period is of high risk for the kidney and these agents
should be avoided as much as possible during this period.
In contrast with previous studies [33], we found no
association between the causative pathogen and the risk
of worsening in renal function in our cohort. Several
studies have linked Staphylococcus species infections
to poor outcome in patients with IE. Several reasons
can be proposed to explain such a difference. First, our
results might suggest that the causal relationship between
Staphylococcus-related IE and kidney injury needs to be
questioned. Indeed, the association between Staphylococcus
species and AKI may be attributable - at least in part -
to the fact that patient with Staphylococcus-related IE
was more likely to be treated with vancomycin and
aminoglycosides. Second, only patients undergoing surgery
were included in our study, therefore, excluding patients
with the most advanced comorbidities, older age or poor
performance status, who were considered too ill or too
old to benefit from surgery. Unexpectedly, age over 65 y
was found to be associated with less impairment in renal
function in the post-operative period. The fact that age
was found to be protective in our cohort further supports
a selection of patients prior to surgery. Indeed, while the
majority of the young patients were considered suitable
for surgery, only the healthiest elderly were selected to
undergo surgical treatment. Such a protective effect of
aging could also be explained by the presence of young
patients in the cohort, in whom the prevalence of post-
operative degradation in renal function was very high.
This interpretation was supported by the fact that when
comparing middle-aged patients (40 to 75 y) to the elderly
(>75 y), the effect of age was no longer significant (OR
0.80, 95% CI 0.55, 1.18, P = 0.26).
Although AKI has been associated with a higher risk
of mortality in patients with IE, the timing and different
contributing factors of AKI have not been clearly explored
so far. In a Spanish multicenter observational study of 705
patients with left-sided IE, using multivariate analysis,
Gálvez-Acebal et al. reported AKI to be associated with
mortality [34]. In our series, we found that post-operative
AKI was clearly associated with in-hospital mortality,
whereas the association between pre-operative AKI
(excluding patients receiving pre-operative RRT) and
mortality was not significant. This suggests the importance
of developing and evaluating perioperative strategies to
prevent the occurrence of post-operative AKI. Interest-
ingly, we observed a sharp difference in mortality between
patients reaching stage 3 AKI and patients with stage 1 or
2, suggesting that all forms of AKI should not be consid-
ered equal in their severity in this setting. Although we
only observed a statistical association between AKI
progression and mortality, we cannot exclude a lack of
power in our cohort to show such an association with
pre-operative AKI.
The statistical analysis used some innovative tools such
as SuperLearner [35] for prediction and TMLE [16,17] for
estimation. The idea behind super learning is to optimize
the prediction performances, accepting the fact that we do
not know anything about the true shape of the underlying
data distribution, so that every kind of parametric
regression model would be biased. SuperLearner allows us
to use a large library of candidate regression algorithms,
parametric of data-adaptive, to honestly evaluate their
prediction performance, and to build a new, tailored
algorithm that is a combination of the best candidates.
As expected from theory, we found that SuperLearner
outperformed each candidate algorithm included in its
library. From such results, we expect SuperLearner to do
the best possible job to estimate the overall probability
distribution of the outcome in our dataset. However, when
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looking at risk factors, we do not really care about the
whole probability distribution of the outcome. In fact, we
do care about a far less dimensional object, which is the
distribution of the outcome given the level of a given
potential risk factor. Our efforts should then focus on
optimizing the bias/variance tradeoff for this object rather
than for the whole outcome probability distribution.
The TMLE aims at targeting our estimation in a way
that the optimal bias/variance tradeoff is achieved for
the parameter of interest.
Our study has several limitations. First, it was performed
in a tertiary center with wide experience in medical and
surgical treatment of patients with IE, potentially limiting
the external validity. Second, our definition of AKI was
based on serum creatinine level and did not include
urine output. Third, we only have limited information
on transfusion requirements. We were only able to evaluate
the risk associated with peri-operative transfusion, but not
the amount of blood transfused, nor the risk associated
with pre- or post-operative transfusion. Fourth, the results
apply to a selected population of patients suitable for
surgery. Finally, despite the SuperLearner procedure,
which is intended to optimize the prediction, our predict-
ive performance was in fact limited, with an AUROC of
0.760 (95% CI 0.694, 0.826) for the SuperLearner weighted
algorithm. Improved predictive performance might first
be achieved by expanding the library of candidate algo-
rithms, as the SuperLearner is at least as good as the best
of its library. Hence, it remains to be investigated if a more
aggressive library will result in further improvements. If
not, one should consider expanding the set of predictive
variables considered, including, potentially, specific kidney
biomarkers.
Conclusions
This study adds evidence to the current literature
suggesting that post-operative AKI following cardiac
surgery with cardiopulmonary bypass results from additive
hits to the kidney. It also identified several modifiable risk
factors of post-operative AKI such as treatment with
vancomycin or aminoglycosides or pre-operative anemia.
Development of post-operative AKI was associated with
in-hospital mortality. Prevention or correction of these
risk factors may improve outcome in patients with IE
undergoing cardiac surgery.
Key messages
 >50% patients undergoing cardiac surgery for IE
develop post-operative AKI
 We identified six risk factors for post-operative AKI,
most being treatment-related, including
vancomycine and aminoglycoside administration,
and contrast agent.
 Pre-operative anemia was associated with an
increased risk of post-operative AKI
 Post-operative AKI was associated with an increased
risk of death.
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